A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
NCT00921895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128
Last updated 2021-11-03
Summary
To engage in a multi-center, prospective, masked clinical trial to investigate a non-invasive, rapid diagnostic test, the RPS Adeno Detector IV's ability to detect the presence of the adenovirus (ADV) antigen in cases of acute conjunctivitis by comparing it to cell culture with confirmatory immunofluorescence (CC-IFA). The polymerase chain reaction (PCR) will be used as a referee for discrepant cases.
Conditions
Interventions
- DEVICE
-
RPS Adeno Detector IV
One time test with the RPS Adeno Detector IV
Sponsors & Collaborators
-
Rapid Pathogen Screening
lead INDUSTRY
Principal Investigators
-
Shachar Tauber, MD · St John's Clinic
-
Jodi Luchs, MD · South Shore Eye Clinic
-
William Trattler, MD · Center For Excellence In Eye Care
-
Thomas Boland, MD · Northeastern Eye Institute
-
Michael DellaVecchia, MD/PhD · Wills Eye Institute
-
Murray Friedberg, MD · Manatee Eye Clinic
-
Chris Starr, MD · Weill Medical College of Cornell University
-
Marguerite McDonald, MD · Ophthalmic Consultants of Long Island
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
NCT03856645 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
NCT02998541 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo
NCT02998554 ·Status: TERMINATED ·Phase: PHASE3
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
NCT01470664 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Adenoviral Patient Infected Days
NCT02472223 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
NCT00223951 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
NCT03749317 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
NCT00244543 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis
NCT01639846 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
NCT02978183 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
NCT01877694 ·Status: COMPLETED ·Phase: PHASE2
-
RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears
NCT01313351 ·Status: COMPLETED
-
FST-100 in the Treatment of Acute Viral Conjunctivitis
NCT01461954 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
NCT02492321 ·Status: COMPLETED ·Phase: PHASE3
-
A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)
NCT02082899 ·Status: COMPLETED ·Phase: PHASE2
-
ADenoVirus Initiative Study in Epidemiology in UK
NCT02112773 ·Status: COMPLETED
-
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
NCT01532336 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
NCT05591755 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01881113 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
NCT00689078 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
NCT05579730 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
NCT00901693 ·Status: TERMINATED ·Phase: PHASE2
-
A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01685242 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
NCT03004924 ·Status: COMPLETED ·Phase: PHASE3